Found 6 hits Enzyme Inhibition Constant Data Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Hexokinase-4
(465/465 = 100%)† (Homo sapiens (Human)) | BDBM50346020
((2R)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-t...)Show SMILES CS(=O)(=O)c1ccc(cc1)[C@@H](CC1CCCC1)C(=O)Nc1nccs1 |r| Show InChI InChI=1S/C18H22N2O3S2/c1-25(22,23)15-8-6-14(7-9-15)16(12-13-4-2-3-5-13)17(21)20-18-19-10-11-24-18/h6-11,13,16H,2-5,12H2,1H3,(H,19,20,21)/t16-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a |
Florida State University
Curated by ChEMBL
| Assay Description Binding affinity to recombinant wild-type human pancreatic glucokinase expressed in Escherichia coli K-12 by isothermal titration calorimetry in pres... |
ACS Med Chem Lett 4: (2013)
Article DOI: 10.1021/ml400061x BindingDB Entry DOI: 10.7270/Q2T72JTM |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Hexokinase-4
(451/465 = 97%)† (Rattus norvegicus) | BDBM50161674
(3-Cyclopentyl-2-(4-methanesulfonyl-phenyl)-N-thiaz...)Show SMILES CS(=O)(=O)c1ccc(cc1)C(CC1CCCC1)C(=O)Nc1nccs1 Show InChI InChI=1S/C18H22N2O3S2/c1-25(22,23)15-8-6-14(7-9-15)16(12-13-4-2-3-5-13)17(21)20-18-19-10-11-24-18/h6-11,13,16H,2-5,12H2,1H3,(H,19,20,21) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a |
OSI Pharmaceuticals
Curated by ChEMBL
| Assay Description Effective concentration for glucokinase activation with 15 mM glucose |
Bioorg Med Chem Lett 15: 1501-4 (2005)
Article DOI: 10.1016/j.bmcl.2004.12.083 BindingDB Entry DOI: 10.7270/Q2HT2NVC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Hexokinase-4
(465/465 = 100%)† (Homo sapiens (Human)) | BDBM50346020
((2R)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-t...)Show SMILES CS(=O)(=O)c1ccc(cc1)[C@@H](CC1CCCC1)C(=O)Nc1nccs1 |r| Show InChI InChI=1S/C18H22N2O3S2/c1-25(22,23)15-8-6-14(7-9-15)16(12-13-4-2-3-5-13)17(21)20-18-19-10-11-24-18/h6-11,13,16H,2-5,12H2,1H3,(H,19,20,21)/t16-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
Takeda California
Curated by ChEMBL
| Assay Description Activation of glucokinase (unknown origin) |
Bioorg Med Chem Lett 23: 2166-71 (2013)
Article DOI: 10.1016/j.bmcl.2013.01.093 BindingDB Entry DOI: 10.7270/Q2W09791 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Hexokinase-4
(465/465 = 100%)† (Homo sapiens (Human)) | BDBM50346020
((2R)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-t...)Show SMILES CS(=O)(=O)c1ccc(cc1)[C@@H](CC1CCCC1)C(=O)Nc1nccs1 |r| Show InChI InChI=1S/C18H22N2O3S2/c1-25(22,23)15-8-6-14(7-9-15)16(12-13-4-2-3-5-13)17(21)20-18-19-10-11-24-18/h6-11,13,16H,2-5,12H2,1H3,(H,19,20,21)/t16-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | n/a | n/a | 690 | n/a | n/a | n/a | n/a |
Pfizer Inc.
Curated by ChEMBL
| Assay Description Activation of human recombinant glucokinase using 6.5 mM glucose by spectrophotometry |
Bioorg Med Chem Lett 19: 3247-52 (2009)
Article DOI: 10.1016/j.bmcl.2009.04.107 BindingDB Entry DOI: 10.7270/Q2PZ595B |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Hexokinase-4
(465/465 = 100%)† (Homo sapiens (Human)) | BDBM50161674
(3-Cyclopentyl-2-(4-methanesulfonyl-phenyl)-N-thiaz...)Show SMILES CS(=O)(=O)c1ccc(cc1)C(CC1CCCC1)C(=O)Nc1nccs1 Show InChI InChI=1S/C18H22N2O3S2/c1-25(22,23)15-8-6-14(7-9-15)16(12-13-4-2-3-5-13)17(21)20-18-19-10-11-24-18/h6-11,13,16H,2-5,12H2,1H3,(H,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | n/a | n/a | 2.67E+4 | n/a | n/a | n/a | n/a |
Chinese Academy of Medical Sciences& Peking Union Medical College
Curated by ChEMBL
| Assay Description Activation of glucokinase (unknown origin) using glucose as substrate |
Eur J Med Chem 76: 182-92 (2014)
Article DOI: 10.1016/j.ejmech.2014.02.024 BindingDB Entry DOI: 10.7270/Q28917CD |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Hexokinase-4
(451/465 = 97%)† (Rattus norvegicus) | BDBM50161674
(3-Cyclopentyl-2-(4-methanesulfonyl-phenyl)-N-thiaz...)Show SMILES CS(=O)(=O)c1ccc(cc1)C(CC1CCCC1)C(=O)Nc1nccs1 Show InChI InChI=1S/C18H22N2O3S2/c1-25(22,23)15-8-6-14(7-9-15)16(12-13-4-2-3-5-13)17(21)20-18-19-10-11-24-18/h6-11,13,16H,2-5,12H2,1H3,(H,19,20,21) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a |
OSI Pharmaceuticals
Curated by ChEMBL
| Assay Description Effective concentration for glucokinase activation with 5 mM glucose |
Bioorg Med Chem Lett 15: 1501-4 (2005)
Article DOI: 10.1016/j.bmcl.2004.12.083 BindingDB Entry DOI: 10.7270/Q2HT2NVC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |